600 related articles for article (PubMed ID: 27682116)
1. Gut Microbiota and Host Reaction in Liver Diseases.
Fukui H
Microorganisms; 2015 Oct; 3(4):759-91. PubMed ID: 27682116
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
3. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
[TBL] [Abstract][Full Text] [Related]
4. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis.
Guohong-Liu ; Qingxi-Zhao ; Hongyun-Wei
Ann Hepatol; 2019; 18(6):796-803. PubMed ID: 31558417
[TBL] [Abstract][Full Text] [Related]
6. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Fukui H
Diseases; 2019 Nov; 7(4):. PubMed ID: 31726747
[TBL] [Abstract][Full Text] [Related]
7. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
Tsai MC; Liu YY; Lin CC; Wang CC; Wu YJ; Yong CC; Chen KD; Chuah SK; Yao CC; Huang PY; Chen CH; Hu TH; Chen CL
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204538
[TBL] [Abstract][Full Text] [Related]
9. Obesity, fatty liver disease and intestinal microbiota.
Arslan N
World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
[TBL] [Abstract][Full Text] [Related]
10. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
De Minicis S; Rychlicki C; Agostinelli L; Saccomanno S; Candelaresi C; Trozzi L; Mingarelli E; Facinelli B; Magi G; Palmieri C; Marzioni M; Benedetti A; Svegliati-Baroni G
Hepatology; 2014 May; 59(5):1738-49. PubMed ID: 23959503
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota and Complications of Liver Disease.
Acharya C; Bajaj JS
Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
[TBL] [Abstract][Full Text] [Related]
12. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of
Wang T; Ishikawa T; Sasaki M; Chiba T
Front Med (Lausanne); 2022; 9():822190. PubMed ID: 35308549
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
14. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie C; Halegoua-DeMarzio D
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota.
He S; Cui S; Song W; Jiang Y; Chen H; Liao D; Lu X; Li J; Chen X; Peng L
mBio; 2022 Apr; 13(2):e0368821. PubMed ID: 35266816
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis.
Nishimura N; Kaji K; Kitagawa K; Sawada Y; Furukawa M; Ozutsumi T; Fujinaga Y; Tsuji Y; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Fukui H; Yoshiji H
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203178
[TBL] [Abstract][Full Text] [Related]
17. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
[TBL] [Abstract][Full Text] [Related]
18. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease.
Augustyn M; Grys I; Kukla M
Clin Exp Hepatol; 2019 Mar; 5(1):1-10. PubMed ID: 30915401
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm.
Ghoshal UC; Goel A; Quigley EMM
Indian J Gastroenterol; 2020 Feb; 39(1):9-21. PubMed ID: 32291578
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota and non-alcoholic fatty liver disease.
Gkolfakis P; Dimitriadis G; Triantafyllou K
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):572-81. PubMed ID: 26663004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]